Making decisions about benefits and harms of medicines
- 1 July 2004
- Vol. 329 (7456), 47-50
- https://doi.org/10.1136/bmj.329.7456.47
Abstract
Introduction Drug regulatory authorities, such as the Medicines and Healthcare Products Regulatory Agency in the United Kingdom and the Food and Drug Administration in the United States, award product licences by assessing the balance between benefit and harm. The decision to revoke a licence generally hangs on evidence of lack of efficacy or risk of serious adverse effects, taking account of the seriousness of the condition and the range of other treatments available. The authorities work at the level of the whole population. But individual patients may believe (rightly in some cases) that a particular regulatory decision is not in their own best interests, and vociferous campaigns sometimes result (box 1). Involvement of patients can be a powerful driver for improving services.5 But both lay people and professionals are susceptible to several biases when making health related decisions (box 2). What can be done to ensure that the care of individual patients is not compromised by regulatory decisions intended to protect the population as a whole, and to encourage objective and dispassionate decision making in the face of cognitive biases?Keywords
This publication has 10 references indexed in Scilit:
- Pharmacogenetics—expectations and realityBMJ, 2004
- Informed choice and balance are victims of the MMR-autism sagaThe Lancet Infectious Diseases, 2004
- Why do doctors use treatments that do not work?BMJ, 2004
- Patient choice and complementary medicineJournal of the Royal Society of Medicine, 2003
- Alosetron and irritable bowel syndromeExpert Opinion on Pharmacotherapy, 2003
- New concerns about thalidomidePublished by Ovid Technologies (Wolters Kluwer Health) ,2002
- The extent of patients' understanding of the risk of treatmentsQuality and Safety in Health Care, 2001
- Presenting Risk Information A Review of the Effects of Framing and other Manipulations on Patient OutcomesJournal of Health Communication, 2001
- The Total Customer Relationship in Health Care: Broadening the BandwidthThe Joint Commission Journal on Quality Improvement, 1997
- Development of the Clozaril Patient Management SystemPsychopharmacology, 1989